Cutaneous Adverse Drug Reactions
$42,092ZIAFY2009CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications & trials
Paper 31959990Paper 29138057Paper 26422655Paper 21422355Paper 20030473Paper 20008856Paper 19687425Paper 19615549Paper 19228742Paper 18779536Paper 18559790
Abstract
In fiscal year 2009, we published the data on hand-foot skin reaction related to sorafenib therapy from three NCI intramural trials to better understand the potential risk factors and possible pathogenesis of this painful treatment-limiting cutaneous adverse effect. This research required multi-specialty collaboration among dermatologists, oncologists, pharmacologists and statisticians. Patients on other investigational therapeutics are being systematically evaluated dermatologically at baseline and while on treatment. In addition to thorough clinical evaluations, subjects may undergo skin biopsies and medical photography.
View original record on NIH RePORTER →